the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 
Market Research Report

US Markets for Neurostimulation Devices 2009

Published by Millennium Research Group Contact us : +1-860-674-8796
Published 2009/02 Content info  
Product code 82027
Price From  US $ 5495 Order/Price list
US $ 5495 Web Access and PDF Download (Single user license)
US $ 8250 Web Access and PDF Download (Corporate use license)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US NEUROSTIMULATION DEVICE MARKET

  • 1.1 Market Overview
  • 1.2 Market Analysis
    • 1.2.1 Major Neurostimulation Indications
    • 1.2.2 Emerging Neurostimulation Indications
    • 1.2.3 Humanitarian Device Exemption
    • 1.2.4 Device Overview
      • 1.2.4.1 Spinal Cord Stimulation
      • 1.2.4.2 Deep Brain Stimulation
      • 1.2.4.3 Sacral Nerve Stimulation
      • 1.2.4.4 Vagus Nerve Stimulation
      • 1.2.4.5 Gastric Stimulation
    • 1.2.5 Market Forecast
      • 1.2.5.1 Economic Assumptions for the Forecast Period
      • 1.2.5.2 US Neurostimulation Device Market
      • 1.2.5.3 Market Drivers and Limiters
  • 1.3 Competitive Analysis
    • 1.3.1 Emerging Competitors

2.0 SPINAL CORD STIMULATION DEVICE MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Market Forecast
      • 2.2.1.1 Market by Implant Type: Initial Implants and Replacements
      • 2.2.1.2 Market by Device Type: Primary Cell and Rechargeable IPGs
      • 2.2.1.3 Emerging Spinal Cord Stimulation Indications
    • 2.2.2 Market Drivers and Limiters
  • 2.3 Competitive Analysis

3.0 DEEP BRAIN STIMULATION DEVICE MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Market Forecast
      • 3.2.1.1 Newly Approved Indication: Obsessive Compulsive Disorder
      • 3.2.1.2 Market by Implant Type: Initial Implants and Replacements
      • 3.2.1.3 Market by Indication
      • 3.2.1.4 Emerging Deep Brain Stimulation Indications
    • 3.2.2 Market Drivers and Limiters
  • 3.3 Competitive Analysis

4.0 SACRAL NERVE STIMULATION DEVICE MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Market Forecast
      • 4.2.1.1 Potential Expanded Indication: Fecal Incontinence
      • 4.2.1.2 Market by Implant Type: Initial Implants and Replacements
    • 4.2.2 Market Drivers and Limiters
  • 4.3 Competitive Analysis

5.0 VAGUS NERVE STIMULATION DEVICE MARKET

  • 5.1 Market Overview
  • 5.2 Market Analysis
    • 5.2.1 Market Forecast
      • 5.2.1.1 Market by Implant Type: Initial Implants and Replacements
      • 5.2.1.2 Emerging Vagus Nerve Stimulation Indications
    • 5.2.2 Market Drivers and Limiters
  • 5.3 Competitive Analysis

6.0 GASTRIC STIMULATION DEVICE MARKET

  • 6.1 Market Overview
  • 6.2 Market Analysis
    • 6.2.1 Market Forecast
      • 6.2.1.1 Market by Implant Type: Initial Implants and Replacements
      • 6.2.1.2 Emerging Gastric Stimulation Indication: Obesity Market Potential
    • 6.2.2 Market Drivers and Limiters
  • 6.3 Competitive Analysis

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

  • Exhibit 1: Neurostimulation Device Market, US (US$), 2007 - 2013
  • Exhibit 2: SCS Units, by Device Type, US, 2007 - 2013
  • Exhibit 3: DBS Units, by Implant Type, as a % of Total, US, 2008
  • Exhibit 4: SNS Device Market, by Indication, US (US$), 2007 - 2013
  • Exhibit 5: VNS Units, by Indication, US, 2007 - 2013
  • Exhibit 6: Gastric Stimulation Market, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 7: Current and Emerging Competitors in the Neurostimulation Device Market, 2008

CHAPTER 1: US NEUROSTIMULATION DEVICE MARKET

  • Exhibit 8: Neurostimulation Device Market, US (US$), 2007 - 2013
  • Exhibit 9: Approved and Emerging Neurostimulation Indications, by Treatment Method, US, 2008
  • Exhibit 10: Neurostimulation Device Units, by Segment, US, 2007 - 2013
  • Exhibit 11: Neurostimulation Device Unit Growth, by Segment, US, 2008 - 2013
  • Exhibit 12: Neurostimulation Device Market, by Segment, US (US$), 2007 - 2013
  • Exhibit 13: Neurostimulation Device Market Growth, by Segment, US, 2008 - 2013
  • Exhibit 14: Drivers of the Neurostimulation Device Market, US
  • Exhibit 15: Limiters of the Neurostimulation Device Market, US
  • Exhibit 16: Leading Competitors in the Neurostimulation Market, by Segment, as a % of Total, US, 2008

CHAPTER 2: SPINAL CORD STIMULATION DEVICE MARKET

  • Exhibit 17: SCS Device Market, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 18: SCS Device Market, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 19: SCS Units, by Implant and Device Type, US, 2007 - 2013
  • Exhibit 20: SCS Unit Growth, by Implant and Device Type, US, 2008 - 2013
  • Exhibit 21: SCS Units, by Implant and Device Type, as a % of Total, US, 2007 - 2013
  • Exhibit 22: SCS Device ASPs, by Device Type, US (US$), 2007 - 2013
  • Exhibit 23: SCS Device ASPs, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 24: SCS Device Market, by Implant and Device Type, US (US$), 2007 - 2013
  • Exhibit 25: SCS Device Market Growth, by Implant and Device Type, US, 2008 - 2013
  • Exhibit 26: SCS Device Market, by Implant and Device Type, as a % of Total, US, 2007 - 2013
  • Exhibit 27: Drivers of the SCS Device Market, US
  • Exhibit 28: Limiters of the SCS Device Market, US
  • Exhibit 29: Leading Competitors in the SCS Device Market, as a % of Total, US, 2008

CHAPTER 3: DEEP BRAIN STIMULATION DEVICE MARKET

  • Exhibit 30: DBS Device Market, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 31: DBS Device Market, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 32: DBS Units, by Implant Type and Indication, US, 2007 - 2013
  • Exhibit 33: DBS Unit Growth, by Implant Type and Indication, US, 2008 - 2013
  • Exhibit 34: DBS Units, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
  • Exhibit 35: DBS Device ASPs, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 36: DBS Device Market, by Implant Type and Indication, US (US$), 2007 - 2013
  • Exhibit 37: DBS Device Market Growth, by Implant Type and Indication, US, 2008 - 2013
  • Exhibit 38: DBS Device Market, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
  • Exhibit 39: Drivers of the DBS Device Market, US
  • Exhibit 40: Limiters of the DBS Device Market, US

CHAPTER 4: SACRAL NERVE STIMULATION DEVICE MARKET

  • Exhibit 41: SNS Device Market, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 42: SNS Device Market, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 43: SNS Units, by Implant Type and Indication, US, 2007 - 2013
  • Exhibit 44: SNS Unit Growth, by Implant Type and Indication, US, 2008 - 2013
  • Exhibit 45: SNS Units, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
  • Exhibit 46: SNS ASPs, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 47: SNS Device Market, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 48: SNS Device Market, by Indication, US (US$), 2007 - 2013
  • Exhibit 49: Drivers of the SNS Device Market, US
  • Exhibit 50: Limiters of the SNS Device Market, US

CHAPTER 5: VAGUS NERVE STIMULATION DEVICE MARKET

  • Exhibit 51: VNS Device Market, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 52: VNS Device Market, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 53: VNS Units, by Implant Type and Indication, US, 2007 - 2013
  • Exhibit 54: VNS Unit Growth, by Implant Type and Indication, US, 2008 - 2013
  • Exhibit 55: VNS Units, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
  • Exhibit 56: VNS ASPs, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 57: VNS Device Market, by Implant Type and Indication, US, 2007 - 2013
  • Exhibit 58: VNS Device Market Growth, by Implant Type and Indication, US, 2008 - 2013
  • Exhibit 59: VNS Market, by Implant Type and Indication, as a % of Total, US, 2007 - 2013
  • Exhibit 60: Drivers of the VNS Device Market, US
  • Exhibit 61: Limiters of the VNS Device Market, US

CHAPTER 6: GASTRIC STIMULATION DEVICE MARKET

  • Exhibit 62: Gastric Stimulation Device Market, US (US$), 2007 - 2013 (Graphical Format)
  • Exhibit 63: Gastric Stimulation Device Market, US (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 64: Gastric Stimulator Units, by Implant Type, US, 2007 - 2013
  • Exhibit 65: Gastric Stimulator ASPs, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 66: Gastric Stimulation Device Market, by Implant Type, US (US$), 2007 - 2013
  • Exhibit 67: Obesity Prevalence, by Obesity Class, US, 2007 - 2013
  • Exhibit 68: Eligible Population upon Initial Approval of Neurostimulation, by Obesity Class, US, 2007 - 2013
  • Exhibit 69: Drivers of the Gastric Stimulation Device Market, US
  • Exhibit 70: Limiters of the Gastric Stimulation Device Market, US

APPENDIX B: SUPPLEMENTAL EXHIBITS

  • Exhibit 71: Neurostimulation Device Market, US (US$), 2007 - 2013 (Detailed Format)
  • Exhibit 72: SCS Units, by Device Type, US, 2007 - 2013 (Detailed Format)
  • Exhibit 73: DBS Units, by Implant Type, as a % of Total, US, 2008 (Detailed Format)
  • Exhibit 74: SNS Device Market, by Indication, US (US$), 2007 - 2013 (Detailed Format)
  • Exhibit 75: VNS Units, by Indication, US, 2007 - 2013 (Detailed Format)
  • Exhibit 76: Gastric Stimulation Market, by Implant Type, US (US$), 2007 - 2013 (Detailed Format)
Back to Top
Please inform me when related publications are released
InfoWatch